Hot Topics in Pharmacotherapy for Neovascular Age-Related Macular Degeneration

E-ISSN： 1873-4286|23|4|535-541

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.4, 2017-03, pp. : 535-541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey Mrejen Sarah Gallego-Pinazo Roberto

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Hot Topics in Pharmacogenetics of Age-Related Macular Degeneration

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 547-550

Bentham Science Publishers

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Potential Therapies

By Chappelow Aimee V. Kaiser Peter K.

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1029-1036

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of age-related macular degeneration (AMD)

By BertelmannThomas KaymakHakan

PHARMAKON, Vol. 3, Iss. 5, 2015-09 ,pp. : 388-399

Govi-Verlag

Access to resources Recommend Favorite

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew Kaiser Peter K

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite